SELLING AGENCY AGREEMENTSelling Agency Agreement • January 9th, 2024 • IntelGenx Technologies Corp. • Pharmaceutical preparations
This engagement letter states certain conditions and assumptions upon which the Offering is premised. Except as expressly provided for herein, with regard to those specific sections that are agreed to be binding, this engagement letter is not intended to be a binding legal document.
SELLING AGENCY AGREEMENT AMENDMENTSelling Agency Agreement • January 9th, 2024 • IntelGenx Technologies Corp. • Pharmaceutical preparations
Reference is made to the letter agreement, dated December 4, 2023 (the "Engagement Letter"), by and between IntelGenx Technologies Corp. (the "Company") and Digital Offering, LLC ("DO" or the "Selling Agent"), relating to the planned primary offering under Regulation A of the Securities Act of 1933, as amended (the "Offering"), by and for the Company consisting of the Company's Preferred Stock.
